The role of innate immune signals in antitumor immunity

References

• Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140:805 - 20; http://dx.doi.org/10.1016/j.cell.2010.01.022; PMID: 20303872
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11:373 - 84; http://dx.doi.org/10.1038/ni.1863; PMID: 20404851
   PubMed Web of Science ®Google Scholar
• Watts C, West MA, Zaru R. TLR signaling regulated antigen presentation in dendritic cells. Curr Opin Immunol 2010; 22:124 - 30; http://dx.doi.org/10.1016/j.coi.2009.12.005; PMID: 20083398
   PubMed Web of Science ®Google Scholar
• Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010; 327:291 - 5; http://dx.doi.org/10.1126/science.1183021; PMID: 20075244
   PubMed Web of Science ®Google Scholar
• Takaoka A, Tamura T, Taniguchi T. Interferon regulatory factor family of transcription factors and regulation of oncogenesis. Cancer Sci 2008; 99:467 - 78; http://dx.doi.org/10.1111/j.1349-7006.2007.00720.x; PMID: 18190617
   PubMed Web of Science ®Google Scholar
• Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004; 21:137 - 48; http://dx.doi.org/10.1016/j.immuni.2004.07.017; PMID: 15308095
   PubMed Web of Science ®Google Scholar
• Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, et al. A critical function for type I interferons in cancer immunoediting. Nat Immunol 2005; 6:722 - 9; http://dx.doi.org/10.1038/ni1213; PMID: 15951814
   PubMed Web of Science ®Google Scholar
• Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H, et al. Integration of interferon-alpha/beta signaling to p53 responses in tumor suppression and antiviral defense. Nature 2003; 424:516 - 23; http://dx.doi.org/10.1038/nature01850
   PubMed Web of Science ®Google Scholar
• Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006; 440:808 - 12; http://dx.doi.org/10.1038/nature04596; PMID: 16489357
   PubMed Web of Science ®Google Scholar
• Blander JM, Medzhitov R. On regulation of phagosome maturation and antigen presentation. Nat Immunol 2006; 7:1029 - 35; http://dx.doi.org/10.1038/ni1006-1029; PMID: 16985500
   PubMed Web of Science ®Google Scholar
• Peng G, Guo Z, Kiniwa Y, Voo KS, Peng W, Fu T, et al. Toll-like receptor 8-mediated reversal of CD4+regulatory T cell function. Science 2005; 309:1380 - 84; PMID: 16123302
   PubMed Web of Science ®Google Scholar
• Peng G, Wang HY, Peng W, Kiniwa Y, Seo KH, Wang RF. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity 2007; 27:334 - 48; http://dx.doi.org/10.1016/j.immuni.2007.05.020; PMID: 17656116
   PubMed Web of Science ®Google Scholar
• Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, et al. Small anti-viral compounds activate immune cells via the TLR7-MyD88-dependent signaling pathway. Nat Immunol 2002; 3:196 - 200; http://dx.doi.org/10.1038/ni758
   PubMed Web of Science ®Google Scholar
• Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S, et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 2005; 11:263 - 70; http://dx.doi.org/10.1038/nm1191; PMID: 15723075
   PubMed Web of Science ®Google Scholar
• Stary G, Bangert C, Tauber M, Strohal R, Kopp T, Stingl G. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J Exp Med 2007; 204:1441 - 51; http://dx.doi.org/10.1084/jem.20070021; PMID: 17535975
   PubMed Web of Science ®Google Scholar
• Krieg AM. Development of TLR9 agonists for cancer therapy. J Clin Invest 2007; 117:1184 - 94; http://dx.doi.org/10.1172/JCI31414; PMID: 17476348
   PubMed Web of Science ®Google Scholar
• Wingender G, Garbi N, Schumak B, Jungerkes F, Endl E, von Bubnoff D, et al. Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO. Eur J Immunol 2006; 36:12 - 20; http://dx.doi.org/10.1002/eji.200535602; PMID: 16323249
   PubMed Web of Science ®Google Scholar
• Mellor AL, Baban B, Chandler PR, Manlapat A, Kahler DJ, Munn DH. CpG oligonucleotides induce splenic CD19+dendritic cells to acquire potent idolamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. J Immunol 2006; 175:5601 - 5
   Web of Science ®Google Scholar
• Moseman EA, Liang X, Dawson AJ, Dawson AJ, Panoskaltsis-Mortari A, Krieg AM, et al. Human plasmacytoid dendritic cells activated by CpG oligonucleotides induce the generation of CD4+CD25+regulatory T cells. J Immunol 2004; 173:4433 - 42; PMID: 15383574
   PubMed Web of Science ®Google Scholar
• Pashenkov M, Goess G, Wagner C, Hormann M, Jandl T, Moser A, et al. Phase II trial of toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma. J Clin Oncol 2006; 24:5716 - 24; http://dx.doi.org/10.1200/JCO.2006.07.9129; PMID: 17179105
   PubMed Web of Science ®Google Scholar
• Manegold C, Gravenor D, Woytowitz D, Mezger J, Hirsh V, Albert G, et al. Radomized phase II trial of a toll-like receptor 9 agonist oligonucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small cell lung cancer. J Clin Oncol 2008; 26:3979 - 86; http://dx.doi.org/10.1200/JCO.2007.12.5807; PMID: 18711188
   PubMed Web of Science ®Google Scholar
• Paulos CM, Wrzesinski C, Kaiser A, Hinrichs CS, Chieppa M, Cassard L, et al. Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Invest 2007; 117:2197 - 204; http://dx.doi.org/10.1172/JCI32205; PMID: 17657310
   PubMed Web of Science ®Google Scholar
• Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13:1050 - 9; http://dx.doi.org/10.1038/nm1622; PMID: 17704786
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Apetoh L, Ghiringhelli F, Andre F, Tesniere A, Kroemer G. The anticancer immune response: indispensable for therapeutic success?. J Clin Invest 2008; 118:1991 - 2001; http://dx.doi.org/10.1172/JCI35180; PMID: 18523649
   PubMed Web of Science ®Google Scholar
• Miyake T, Kumagai Y, Kato H, Guo Z, Matsushita K, Satoh T, et al. Poly I:C-induced activation of Nk cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways. J Immunol 2009; 183:2522 - 8; http://dx.doi.org/10.4049/jimmunol.0901500; PMID: 19635904
   PubMed Web of Science ®Google Scholar
• McCartney S, Vermi W, Gilfillan S, Cella M, Murphy TL, Schreiber RD, et al. Distinct and complementary functions of MDA5 and TLR3 in poly (I:C)-mediated activation of NK cells. J Exp Med 2009; 206:2967 - 76; http://dx.doi.org/10.1084/jem.20091181; PMID: 19995959
   PubMed Web of Science ®Google Scholar
• Akazawa T, Ebihara T, Okuno M, Okuda Y, Shingai M, Tsujimura K, et al. Antitumor NK activation induced by the toll-like receptor 3-TICAM (TRIF) pathway in myeloid dendritic cells. Proc Natl Acad Sci USA 2007; 104:252 - 7; http://dx.doi.org/10.1073/pnas.0605978104; PMID: 17190817
   PubMed Web of Science ®Google Scholar
• Salaun B, Coste I, Rissoan MC, Lebecque SJ, Renno T. TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 2006; 176:4894 - 901; PMID: 16585585
   PubMed Web of Science ®Google Scholar
• Besch R, Poeck H, Hohenauer T, Hohenauer T, Senft D, Hacker G, et al. Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J Clin Invest 2009; 119:2399 - 411; PMID: 19620789
   PubMed Web of Science ®Google Scholar
• Kübler K, Gehrke N, Riemann S, Bohnert V, Zillinger T, Hartmann E, et al. Targeted activation of RNA helicase retinoic acid-inducible gene-I induces proimmunogenic apoptosis of human ovarian cancer cells. Cancer Res 2010; 70:5293 - 304; http://dx.doi.org/10.1158/0008-5472.CAN-10-0825; PMID: 20551064
   PubMed Web of Science ®Google Scholar
• Poeck H, Besch R, Maihoefer C, Maihoefer C, Renn M, Tormo D, et al. 5′-Triphosphate-siRNA turning gene silencing and Rig-I activation against melanoma. Nat Med 2008; 14:1256 - 63; http://dx.doi.org/10.1038/nm.1887; PMID: 18978796
   PubMed Web of Science ®Google Scholar
• Anz D, Koelzer VH, Moder S, Thaler R, Schwerd T, Lahl K, et al. Immunostimulatory RNA blocks suppression by regulatory T cells. J Immunol 2010; 184:939 - 46; http://dx.doi.org/10.4049/jimmunol.0901245; PMID: 19966212
   PubMed Web of Science ®Google Scholar
• Pan M, Geng S, Xiao S, Ren J, Liu Y, Li X, et al. Apoptosis induced by synthetic retinoic acid CD437 on human melanoma A375 cells involves RIG-I pathway. Arch Dermatol Res 2009; 301:15 - 20; http://dx.doi.org/10.1007/s00403-008-0902-x; PMID: 18936944
   PubMed Web of Science ®Google Scholar
• Ting JP, Duncan JA, Lei Y. How the non-inflammasome NLRs function in the innate immune system?. Science 2010; 327:286 - 90; http://dx.doi.org/10.1126/science.1184004; PMID: 20075243
   PubMed Web of Science ®Google Scholar
• Chen G, Shaw MH, Kim YG, Nunez G. NOD-like receptors: role in innate immunity and inflammatory disease. Annu Rev Pathol 2009; 4:365 - 98; http://dx.doi.org/10.1146/annurev.pathol.4.110807.092239; PMID: 18928408
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 2001; 411:603 - 6; http://dx.doi.org/10.1038/35079114; PMID: 11385577
   PubMed Web of Science ®Google Scholar
• Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezaed JP, Belaiche J, et al. Association of NOD2 leucin-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001; 411:599 - 603; http://dx.doi.org/10.1038/35079107; PMID: 11385576
   PubMed Web of Science ®Google Scholar
• da Silva Correia J, Miranda YY, Austin-Brown N, Hsu J, Mathison J, Xiang R, et al. Nod1-dependent control of tumor growth. Proc Natl Acad Sci USA 2006; 103:1840 - 5; http://dx.doi.org/10.1073/pnas.0509228103; PMID: 16446438
   PubMed Web of Science ®Google Scholar
• Chen GY, Shaw MH, Redondo G, Nunez G. The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. Cancer Res 2008; 68:10060 - 7; http://dx.doi.org/10.1158/0008-5472.CAN-08-2061; PMID: 19074871
   PubMed Web of Science ®Google Scholar
• Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440:237 - 41; http://dx.doi.org/10.1038/nature04516; PMID: 16407889
   PubMed Web of Science ®Google Scholar
• Schroder K, Zhou R, Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger?. Science 2010; 327:296 - 300; http://dx.doi.org/10.1126/science.1184003; PMID: 20075245
   PubMed Web of Science ®Google Scholar
• Schroder K, Tshopp J. The inflammasome. Cell 2010; 140:821 - 32; http://dx.doi.org/10.1016/j.cell.2010.01.040; PMID: 20303873
   PubMed Web of Science ®Google Scholar
• Allen IC, TeKippe EM, Woodford RM, Uronis JM, Holl EK, Rogers AB, et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 2010; 207:1045 - 56; http://dx.doi.org/10.1084/jem.20100050; PMID: 20385749
   PubMed Web of Science ®Google Scholar
• Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SG, et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009; 461:282 - 6; http://dx.doi.org/10.1038/nature08296; PMID: 19741708
   PubMed Web of Science ®Google Scholar
• Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010; 11:136 - 40; http://dx.doi.org/10.1038/ni.1831; PMID: 20023662
   PubMed Web of Science ®Google Scholar
• Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009; 15:1170 - 8; http://dx.doi.org/10.1038/nm.2028; PMID: 19767732
   PubMed Web of Science ®Google Scholar
• Faustin B, Chen Y, Zhai D, Negrate GL, Lartigue L, Satterthwait A, et al. Mechanisms of Bcl-2 and Bcl-X(L) inhibition of NLRP1 inflammasome: loop domain-dependent suppression of ATP binding and oligomerization. Proc Natl Acad Sci USA 2009; 106:3935 - 40; http://dx.doi.org/10.1073/pnas.0809414106
   PubMed Web of Science ®Google Scholar
• Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T, et al. Loss of Autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008; 456:264 - 8; http://dx.doi.org/10.1038/nature07383; PMID: 18849965
   PubMed Web of Science ®Google Scholar
• Bürckstummer T, Baumann C, Bluml S, Dixit E, Durnberger G, Jahn H, et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 2009; 10:266 - 72; http://dx.doi.org/10.1038/ni.1702; PMID: 19158679
   PubMed Web of Science ®Google Scholar
• Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009; 458:509 - 13; http://dx.doi.org/10.1038/nature07710; PMID: 19158676
   PubMed Web of Science ®Google Scholar
• Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009; 458:514 - 8; http://dx.doi.org/10.1038/nature07725; PMID: 19158675
   PubMed Web of Science ®Google Scholar
• Roberts TL, Idris A, Kelly JA, Burnton CM, Hodgson S, Hardy LL, et al. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 2009; 323:1057 - 60; http://dx.doi.org/10.1126/science.1169841; PMID: 19119196
   PubMed Web of Science ®Google Scholar
• DeYoung KL, Ray ME, Su YA, Anzick SL, Johnstone RW, Trapani JA, et al. Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma. Oncogene 1997; 15:453 - 7; http://dx.doi.org/10.1038/sj.onc.1201206; PMID: 9242382
   PubMed Web of Science ®Google Scholar
• Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 2009; 7:99 - 109; http://dx.doi.org/10.1038/nrmicro2070; PMID: 19148178
   PubMed Web of Science ®Google Scholar
• Patsps G, Germann A, Gebert J, Dihlmann S. Restoration of absent in melanoma 2 (AIM2) induces G2/M cell cycle arrest and promotes invasion of colorectal cancer cells. Int J Cancer 2009; 126:1838 - 49
   Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860 - 7; http://dx.doi.org/10.1038/nature01322; PMID: 12490959
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140:883 - 99; http://dx.doi.org/10.1016/j.cell.2010.01.025; PMID: 20303878
   PubMed Web of Science ®Google Scholar